ADARx

ADARx Pharmaceuticals, located in San Diego, is a biotechnology company dedicated to transforming cutting-edge science into life-saving therapies. ADARx is developing a proprietary RNA-targeting drug platform, including oligonucleotides for inhibition, degradation, and editing, as well as novel oligonucleotide delivery technologies. ADARx is currently focused on diseases in three therapeutic areas: genetic disorders, cardiometabolic diseases, and central nervous system (CNS) diseases. The focus of the company’s future research is targeting RNA as the goal of our drug discovery, with the capability to investigate a wide range of diseases, and will continue to add more disease targets to our pipeline in areas of unmet medical needs.